BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 29717062)

  • 1. VEGF-neuropilin-2 signaling promotes stem-like traits in breast cancer cells by TAZ-mediated repression of the Rac GAP β2-chimaerin.
    Elaimy AL; Guru S; Chang C; Ou J; Amante JJ; Zhu LJ; Goel HL; Mercurio AM
    Sci Signal; 2018 May; 11(528):. PubMed ID: 29717062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropilin-2 acts a critical determinant for epithelial-to-mesenchymal transition and aggressive behaviors of human head and neck cancer.
    Ahn MH; Kim JH; Choi SJ; Kim HJ; Park DG; Oh KY; Yoon HJ; Hong SD; Lee JI; Shin JA; Cho SD
    Cell Oncol (Dordr); 2024 Apr; 47(2):497-511. PubMed ID: 37787967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential expression profiles of glycosphingolipids in human breast cancer stem cells vs. cancer non-stem cells.
    Liang YJ; Ding Y; Levery SB; Lobaton M; Handa K; Hakomori SI
    Proc Natl Acad Sci U S A; 2013 Mar; 110(13):4968-73. PubMed ID: 23479608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of proprotein convertases activity results in repressed stemness and invasiveness of cancer stem cells in gastric cancer.
    Zaafour A; Seeneevassen L; Nguyen TL; Genevois C; Nicolas N; Sifré E; Giese A; Porcheron C; Descarpentrie J; Dubus P; Khatib AM; Varon C
    Gastric Cancer; 2024 Mar; 27(2):292-307. PubMed ID: 38280128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. VGLL1 stabilization of cytoplasmic TAZ promotes EGFR expression and maintains tumor initiating cells in breast cancer independent of TEAD.
    Parimita S; Das A; Samanta S
    Cell Signal; 2024 Jun; 118():111120. PubMed ID: 38417636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TNF-α increases breast cancer stem-like cells through up-regulating TAZ expression via the non-canonical NF-κB pathway.
    Liu W; Lu X; Shi P; Yang G; Zhou Z; Li W; Mao X; Jiang D; Chen C
    Sci Rep; 2020 Feb; 10(1):1804. PubMed ID: 32019974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rac1 GTPase: a "Rac" of all trades.
    Bosco EE; Mulloy JC; Zheng Y
    Cell Mol Life Sci; 2009 Feb; 66(3):370-4. PubMed ID: 19151919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IMP3 Stabilization of WNT5B mRNA Facilitates TAZ Activation in Breast Cancer.
    Samanta S; Guru S; Elaimy AL; Amante JJ; Ou J; Yu J; Zhu LJ; Mercurio AM
    Cell Rep; 2018 May; 23(9):2559-2567. PubMed ID: 29847788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic anti-angiogenic treatment effects by dual FGFR1 and VEGFR1 inhibition in FGFR1-amplified breast cancer.
    Golfmann K; Meder L; Koker M; Volz C; Borchmann S; Tharun L; Dietlein F; Malchers F; Florin A; Büttner R; Rosen N; Rodrik-Outmezguine V; Hallek M; Ullrich RT
    Oncogene; 2018 Oct; 37(42):5682-5693. PubMed ID: 29970903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid phenotyping of cancer stem cells using multichannel nanosensor arrays.
    Geng Y; Goel HL; Le NB; Yoshii T; Mout R; Tonga GY; Amante JJ; Mercurio AM; Rotello VM
    Nanomedicine; 2018 Aug; 14(6):1931-1939. PubMed ID: 29778888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The VEGF receptor neuropilin 2 promotes homologous recombination by stimulating YAP/TAZ-mediated Rad51 expression.
    Elaimy AL; Amante JJ; Zhu LJ; Wang M; Walmsley CS; FitzGerald TJ; Goel HL; Mercurio AM
    Proc Natl Acad Sci U S A; 2019 Jul; 116(28):14174-14180. PubMed ID: 31235595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. VEGF/Neuropilin Signaling in Cancer Stem Cells.
    Mercurio AM
    Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30678134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. VEGF in Signaling and Disease: Beyond Discovery and Development.
    Apte RS; Chen DS; Ferrara N
    Cell; 2019 Mar; 176(6):1248-1264. PubMed ID: 30849371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrophage-Derived Neuropilin-2 Exhibits Novel Tumor-Promoting Functions.
    Roy S; Bag AK; Dutta S; Polavaram NS; Islam R; Schellenburg S; Banwait J; Guda C; Ran S; Hollingsworth MA; Singh RK; Talmadge JE; Muders MH; Batra SK; Datta K
    Cancer Res; 2018 Oct; 78(19):5600-5617. PubMed ID: 30111533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new Neu-a syngeneic model of spontaneously metastatic HER2-positive breast cancer.
    Baugh AG; Gonzalez E; Narumi VH; Kreger J; Liu Y; Rafie C; Castanon S; Jang J; Kagohara LT; Anastasiadou DP; Leatherman J; Armstrong T; Chan I; Karagiannis GS; Jaffee EM; MacLean A; Torres ETR
    Clin Exp Metastasis; 2024 May; ():. PubMed ID: 38717519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-cell sequencing reveals VEGFR as a potential target for CAR-T cell therapy in chordoma.
    Wu H; Li X; Zhang B; Liu P; Qi M; Du Y; Zhang C; Duan W; Chen Z
    Br J Cancer; 2024 Jun; 130(10):1609-1620. PubMed ID: 38605247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Orchestrating Resilience: How Neuropilin-2 and Macrophages Contribute to Cardiothoracic Disease.
    Dhupar R; Powers AA; Eisenberg SH; Gemmill RM; Bardawil CE; Udoh HM; Cubitt A; Nangle LA; Soloff AC
    J Clin Med; 2024 Mar; 13(5):. PubMed ID: 38592275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The inhibitory effect of apatinib on different small cell lung cancer cells and in lung cancer-bearing mice and patients.
    Liu M; Li H; Guo R; Yu X; Li Y
    Clin Respir J; 2024 Feb; 18(2):e13738. PubMed ID: 38403875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Profiling and targeting cancer stem cell signaling pathways for cancer therapeutics.
    Borlongan MC; Wang H
    Front Cell Dev Biol; 2023; 11():1125174. PubMed ID: 37305676
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.